Few With Myelodysplastic Syndromes Receive Hypomethylating Agents

MONDAY, Aug. 11, 2025 (HealthDay News) -- Few patients with myelodysplastic syndromes (MDS) receive treatment with hypomethylating agents (HMAs), with evidence

See Full Page

Interests (0)

Settings

Few With Myelodysplastic Syndromes Receive Hypomethylating Agents

Women at risk of DYING earlier if they don't have enough sex - as scientists pinpoint optimum monthly bonk rate

Are Bright Lights Bad for Your Eyes?

Summer COVID-19 Wave Builds: Nimbus Variant Still Dominant As Stratus Rises

Conch shell blowing could help treat common snoring disease

Prophylactic Antibiotics May Be of No Use in Cirrhosis With Upper GI Bleeding

Restaurant inspection update: Mold, expired food and ‘deceased pests’ reported

WA homeless patients have a lot to lose under Trump’s Medicaid changes

Man Dead, 9 Others Hospitalized After Eating Sandwiches amid Botulism Outbreak

Deranged Trump admin has replaced heart disease as America's biggest killer

Giannis Antetokounmpo Future Update: Shams Charania Ends Bucks Fans’ Wait With New Scoop Giannis Antetokounmpo’s trade saga nears a turning point, as four NBA teams' experiences add more pressure to M

FDA Approves Ajovy for Migraine Prevention in Children and Teens

AI System Can Train Surgeons to Place Clamp on Renal Artery

Blowing Conch Shell Tied to Improved Obstructive Sleep Apnea Measures

Clinton and Cristin Brink murdered at Arkansas Devil's Den State Park

One killed, five injured in Chicago mass shooting

Trump has been on a roll for the ages — but blowback could be looming

Trump to Meet Putin in Alaska to Discuss Ukraine Conflict

$7,000 in Labubu Dolls Stolen from La Puente Store

Officer Killed in Shooting Near CDC, Suspect Identified

Trump Sends 120 FBI Agents to DC Amid Crime Crackdown Threat: Report

An awful Trump secret is about to come crashing into the open

Federal Judge Halts Construction at Migrant Detention Facility

Baltimore Police Investigate Mass Shooting with Six Victims